While there is ongoing research to develop better tools like biochemical markers to differentiate fibrosis stage in MASH patients, the only standard currently used in MASH clinical studies involves ...

A new study finds semaglutide is linked to an increased risk of vision loss associated with a rare eye condition, but cases ...

These weight management drugs, which mimic natural hormones that regulate insulin and glucose levels, have become increasingly popular due to their effectiveness in promoting weight loss. However, ...

Weight loss tops many folks' list of New Year's resolutions, and lots of people are turning to cutting-edge weight-loss drugs ...

This could start to bring down the cost of brand-name competitors—here's who may get to use it, and one major difference from ...

Figuring out if GLP-1s are the right fit for you isn’t something to tackle alone—and that’s where Mochi Health comes in.

Generic Victoza is a GLP-1 receptor agonist indicated to improve glycemic control in adults and pediatric patients aged 10 ...

What happened with Novo Nordisk stock? On Dec. 20, Novo announced results from a phase 3 clinical trial surrounding one of ...

Intuitively, it would seem that GLP-1 use for obesity would reduce overall medical costs despite the increase in drug ...

Topline data were announced from a phase 3 trial evaluating CagriSema in overweight or obese patients without type 2 diabetes ...

Lithocholic acid (LCA), a metabolite induced by calorie restriction (CR), activates AMPK and mimics anti-aging benefits. A ...